HIV-patients affected by lipodystrophy that are undergoing anti- retroviral therapy suffer from a whole complex of symptoms consisting of dysfunctions of the fat distribution and changes of the metabolism. It results in the peripheral loss of subcutaneous fat (face, arms, legs, posterior) and the development of central fat deposits (abdomen, neck, chest).